NEXGEL Reports Fourth Quarter and Full Year 2022 Financial Results
27 mars 2023 16h05 HE
|
NEXGEL, INC.
2022 revenue increased 32% YoY to $2.05 million, while gross profit margin improved As of December 31, 2022, had over $6.6 million in cash and securities which is sufficient to operate through 2025 ...
NEXGEL to Report Fourth Quarter and Full Year 2022 Financial Results on March 27th
15 mars 2023 07h30 HE
|
NEXGEL, INC.
Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., March 15, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading...
NEXGEL Partners with Former Major League Lacrosse Player, Greg “The Beast” Gurenlian, and The Face-Off Academy to Fight Turf Burn with Turfguard
07 mars 2023 07h30 HE
|
NEXGEL, INC.
Gurenlian and his training camp to use NEXGEL’s Turfguard for turf burn in lacrosse LANGHORNE, Pa., March 07, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (NASDAQ: NXGL, NXGLW), (“NEXGEL” or the...
NEXGEL Acquires 50% Interest in Newly Formed Joint Venture with C.G. Laboratories for Converting and Packaging Business
02 mars 2023 08h30 HE
|
NEXGEL, INC.
Strategic investment in CG Labs’ revenue generating and already profitable business increases NEXGEL’s capacity, improves margins and streamlines supply chain LANGHORNE, Pa., March 02, 2023 (GLOBE...
NEXGEL Launches Turfguard to Treat Painful Turf Burns and Protect Sports-Related Wounds
08 déc. 2022 07h30 HE
|
NEXGEL, INC.
LANGHORNE, Pa., Dec. 08, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (NASDAQ: NXGL, NXGLW), (“NEXGEL” or the “Company”), a leading provider of ultra-gentle, high-water-content hydrogel products for...
NEXGEL Reports Third Quarter 2022 Financial Results
08 nov. 2022 16h11 HE
|
NEXGEL, INC.
Revenue increased 69.6% YoY while gross profit margin improved both sequentially and YoY to 26% LANGHORNE, Pa., Nov. 08, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ:...
NEXGEL to Report Third Quarter 2022 Financial Results on November 8th
02 nov. 2022 09h00 HE
|
NEXGEL, INC.
Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., Nov. 02, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading...
NEXGEL Reports Positive Results from Proof-of-Concept Study for its Diclofenac Hydrogel Pain Treatment
25 oct. 2022 08h00 HE
|
NEXGEL, INC.
LANGHORNE, Pa., Oct. 25, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for...
NEXGEL Develops New Hydrogel Patch to Treat Amblyopia
20 oct. 2022 08h00 HE
|
NEXGEL, INC.
Patch Will Be Available to Ophthalmologists and Optometrists in 1H 2023 Global Amblyopia Market Expected to Reach Over $6 Billion by 2027 LANGHORNE, Pa., Oct. 20, 2022 (GLOBE NEWSWIRE) -- NEXGEL,...
NEXGEL to Participate in Upcoming Investor Conferences in October 2022
04 oct. 2022 07h30 HE
|
NEXGEL, INC.
LANGHORNE, Pa., Oct. 04, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for...